Humana AB Stock: price and insider trades · Sweden

Humana AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. 11 insiders have disclosed 14 filings since 18 October 2025.

Open-market activity splits into 4 purchases totalling €24k and 10 sales totalling €85.7M; 4 insiders sit on the buying side and 10 insiders on the selling side. The net balance comes to €85.7M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 2 board members, 1 senior executive and 1 chief executive. Fredrik Strömholm filed the largest sale, €84.9M, on 2 October 2026, which represents 33.1% of the company's market value.

In the case of 2 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 234 days ago, on 26 February 2026. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 14 filings here. Over the whole record (from 2025), the tally stands at 6 purchases and 10 sales.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.